Oct 2026· Genes· Vol 17, pp. 1374· 0 citations· 15 references
TL;DR
This case highlights the importance of systematic family history and targeted genetic workup in patients with drug-resistant epilepsy, adds preliminary evidence for fenfluramine beyond Dravet and Lennox–Gastaut syndromes, and illustrates the potential of precise genetic diagnosis to guide treatment in SCN1A-related GEFS+.
Abstract
Background: SCN1A-related genetic epilepsy with febrile seizures plus (GEFS+) is characterized by marked intrafamilial phenotypic variability, ranging from asymptomatic variant carriers to severe, drug-resistant epilepsy. Methods and Results: We present a two-generation family in which two clinically affected sisters inherited a causative heterozygous SCN1A missense variant (c.3824G>A) from the mother, who likely carries the variant in a mosaic state. The proband, a 23-year-old woman, presented with a long-standing drug-resistant febrile and afebrile epilepsy with onset in early infancy, complicated by mild intellectual disability, impulse control disorder, and behavioral comorbidities, leading to a delayed genetic diagnosis in adulthood. Following insufficient control by multiple antiseizure medications, fenfluramine was introduced at age 21, resulting in complete seizure freedom sustained over two years, alongside measurable neuropsychological improvements in cognition, adaptive functioning, socialization and quality of life. Conclusions: This case highlights the importance of systematic family history and targeted genetic workup in patients with drug-resistant epilepsy, adds preliminary evidence for fenfluramine beyond Dravet and Lennox–Gastaut syndromes, and illustrates the potential of precise genetic diagnosis to guide treatment in SCN1A-related GEFS+.
Case Presentation: A 7-year-old girl, born at term without perinatal complications, presented with global developmental delay and epilepsy onset at 6 months of age, characterized by absence and atonic seizures. The patient experienced more than 50 seizures per day, with frequent sudden falls due to hypotonia. Hypotonia...
Rayssa Cabral Costa, Anna Maria Krewer Sott, N. Nascimento et al.· ANPAbstract_CBN26· 0 citations
Pathogenic variants in SCN1A are associated with a broad and overlapping spectrum of epilepsies, ranging from febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+) to severe developmental and epileptic encephalopathies (DEEs), most notably Dravet syndrome. SCN1A encodes the voltage-gated sodium chann...
J. Moon, Tae-Hoon Eom· Current Issues in Molecular...· 0 citations
Case Presentation: Patient B.V.T.T., male, 12 years old, with autism spectrum disorder, neurodevelopmental delay, and epilepsy onset at 4 years and 2 months of age. From the beginning, he presented photosensitivity and absence seizures, later progressing to frequent generalized tonic-clonic seizures, with an average of...
Hadassa Tonussi Rossette Do Valle Tonussi, Sabrina da Silva Oliveira, Marcus Vinícius Guirado Teixeira Guirado et al.· ANPAbstract_CBN26· 0 citations
Functional neuroimaging findings supported the presence of a right temporal epileptogenic focus, even in the absence of an evident structural lesion on magnetic resonance imaging, in a male patient with onset of epileptic seizures at 11 months of age.
Steffany Pereira de Sousa Barbosa, Isabela Lobato Goes de Albuquerque, Laísy Lins Gonçalves Cabral et al.· ANPAbstract_CBN26· 0 citations
Case Presentation: Dravet syndrome is a rare developmental and epileptic encephalopathy characterized by early-onset drug-resistant seizures and progressive neurological deterioration. Most cases are associated with SCN1A mutations, which encode the neuronal sodium channel NaV1.1, essential for inhibitory GABAergic int...
Carlos Eduardo Mendonça Oliveira, H. Siqueira, Hingrid Cristine Arruda Oliveira et al.· ANPAbstract_CBN26· 0 citations
Epileptic and/or developmental encephalopathies (DEEs) represent a particularly severe subgroup of early-onset epilepsies, with an identifiable genetic aetiology in 30–50% of cases. Mutations in the
SCN1A
,
SCN2A
, and
SCN8A
genes, encoding the α-subunits of the voltage-gated sodium channels Nav1.1, Nav1....
Arianna De Leonardis, A. Spalice, M. Capponi et al.· Italian Journal of Pediatric...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.